Redica Systems Announces US$30 Million Series B Led by Savant Growth to Bring New Analytics and Compliance Platform to FDA-Regulated Life Sciences Companies

(US and Canada) Redica Systems, a cloud-based data intelligence platform serving FDA-regulated industries, announced it has secured a US$30 million Series B led by Savant Growth, with participation from existing investor Rock Creek Capital. Redica will use this round to extend its lead as a quality and regulatory intelligence platform and fuel product innovation, which will accelerate customer value and expand the company's total addressable market.

Redica Systems' unique platform enables quality and safety professionals in the pharmaceutical, medical device, and food industries to take a proactive, risk-based approach to decision making and regulatory compliance. Utilizing Redica's proprietary data sourcing and machine learning models, combined with purpose-built visualizations, customers gain immediate access to actionable, high-quality data analytics and insights. Currently, 19 of the top 20 pharma companies and nine of the top ten medical device firms rely on Redica's platform to improve their Quality Unit and regulatory compliance.

"Redica serves as a strategic partner to our customers, and as market dynamics continue to change, Redica is committed to delivering the capabilities that make it easy to keep up with the evolving regulations and enforcement," said Michael de la Torre, Chief Executive Officer at Redica Systems. "The investment led by Savant Growth will help accelerate our development efforts to meet the growing demands of the FDA-regulated industries we serve."

"The Redica Systems platform is a fundamentally different approach to industry compliance," said Javier Rojas, founder, and managing partner at Savant Growth. "Redica's ability to generate and surface high-quality datasets and make organizational information possible is what sets the company apart. We are excited to help Redica continue its market momentum and growth."